These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12665899)

  • 41. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus.
    Zhang S; Xiao L; Zhou H; Yu Z; Chen H; Guo A; Jin M
    J Virol Methods; 2008 Dec; 154(1-2):99-103. PubMed ID: 18812190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination.
    Breathnach CC; Rudersdorf R; Lunn DP
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):127-36. PubMed ID: 15010222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.
    Hackett CJ; Askonas BA
    Immunology; 1982 Mar; 45(3):431-8. PubMed ID: 6977485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
    Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
    J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of primary and secondary responses to sheep red blood cells and influenza virus in BALB/c mice by recombinant human interleukin-2.
    Mumcuoglu M; Zakay-Rones Z; Weiss L; Slavin S
    Exp Hematol; 1996 Nov; 24(13):1516-20. PubMed ID: 8950235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
    Zou P; Liu W; Chen YH
    Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A humanized anti-M2 scFv shows protective in vitro activity against influenza.
    Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR
    Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An overview of serum antibody responses to influenza virus antigens.
    Couch RB
    Dev Biol (Basel); 2003; 115():25-30. PubMed ID: 15088772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metaplasia of the lung respiratory epithelium and antibody dynamics in mice repeatedly infected with various subtypes of influenza virus A.
    Wilczyński J; Kruś S; Semkow R; Loza-Tulimowska M
    Acta Microbiol Pol; 1984; 33(1):45-9. PubMed ID: 6205549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies for the control of influenza virusvaccines.
    van de Donk HJ; de Jong JC; van Olderen MF; Osterhaus AD
    Dev Biol Stand; 1984; 57():251-5. PubMed ID: 6526141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.
    Miller A; Center RJ; Stambas J; Deliyannis G; Doherty PC; Howard JL; Turner SJ; Purcell DF
    Vaccine; 2008 Oct; 26(44):5641-8. PubMed ID: 18761047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of blocking ELISA for detection of antibodies against avian influenza virus of the H7 subtype.
    Shien JH; Fu LF; Wu JR; Cheng MC; Shieh HK; Chang PC
    J Microbiol Immunol Infect; 2008 Oct; 41(5):369-76. PubMed ID: 19122917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.